Education
About Us
Working with TipRanks
Follow Us
TC Biopharm (Holdings) (TCBPY)
OTHER OTC:TCBPY
TCBPY Stock Chart & Stats
$0.10
--
Market closed
$0.10
--
Day’s Range― - ―
52-Week Range$0.03 - $8.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)8.91K
Market Cap
$63.83K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.38
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,103,054
10 Day Avg. Volume7,787
30 Day Avg. Volume8,914
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TC Biopharm (Holdings) News
TCBPY FAQ
What was TC Biopharm (Holdings)’s price range in the past 12 months?
TC Biopharm (Holdings) lowest stock price was $0.03 and its highest was $8.20 in the past 12 months.
What is TC Biopharm (Holdings)’s market cap?
TC Biopharm (Holdings)’s market cap is $63.83K.
When is TC Biopharm (Holdings)’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were TC Biopharm (Holdings)’s earnings last quarter?
Currently, no data Available
Is TC Biopharm (Holdings) overvalued?
According to Wall Street analysts TC Biopharm (Holdings)’s price is currently Overvalued.
Does TC Biopharm (Holdings) pay dividends?
TC Biopharm (Holdings) does not currently pay dividends.
What is TC Biopharm (Holdings)’s EPS estimate?
TC Biopharm (Holdings)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TC Biopharm (Holdings) have?
TC Biopharm (Holdings) has 2,103,054 shares outstanding.
What happened to TC Biopharm (Holdings)’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of TC Biopharm (Holdings)?
Currently, no hedge funds are holding shares in TCBPY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
TC Biopharm (Holdings)
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an unmodified cell therapy used in the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat COVID-19. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.
Technical Analysis
Scinai Immunotherapeutics
―
Dermata Therapeutics
―
Psyence Biomedical
―
Conduit Pharmaceuticals
―
Virax Biolabs Group Ltd. Class A
―